The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...

(Reuters) -A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial ...

The Department of Health and Human Services and the Food and Drug Administration, launched a new initiative to ensure infant ...

Health and Human Services Secretary Robert F. Kennedy Jr. is planning to meet Tuesday with executives of companies that make ...

The FDA would embark on a comprehensive look at the nutrients used in infant formula and increase testing for heavy metals ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where ...

Juries in the first two cases ruled against the formula makers, delivering verdicts of $495 million against Abbott Laboratories and $60 million against Mead Johnson. The case that wrapped up in ...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few ...

Exclusive new testing by Consumer Reports highlights safer formulas while also identifying some that contain potentially ...